Hintergrund: Einige Eigenschaften des Blutes können sich post mortem ändern. Hierdurch kann es zu falsch-negativen oder falsch-positiven Ergebnissen in der infektionsserologischen Testung kommen. Die meisten CE-markierten infektionsserologischen Tests sind nicht für die Verwendung von postmortalem Blut validiert. Da die infek tionsserologischen Ergebnisse für die Freigabe von Geweben zu Transplantationszwecken vorgeschrieben ist, muss die jeweilige Testung validiert werden. Methoden: Prae-und Post-mortem-Seren von 20 Hornhautspendern wurden auf Anti-HIV-1/2, Anti-HCV, HBsAg und Anti-HBc mit dem Siemens-BEP-III-Automatic-System getestet und miteinander verglichen. Negative Post-mortem-Seren wurden darüber hinaus mit Standardseren (PEI Anti-HCV IgG, PEI HBsAg ad 1000 Standard, Anti-HBc-IgG (WHO) NIBSC 95/522, PEI Anti-HIV-IV) in zwei Konzentrationen gespikt (low level und high level) und getestet. Ergebnisse: Alle Prae-mortem-Seren wurden korrekt negativ für alle Parameter getestet. Keine der Post-mortem-Proben wurde falsch-positiv getestet. Keine der gespikten Post-mortemProben wurde falsch-negativ getestet. Technische Fehler traten bei der Validierung auf, konnten aber erkannt und beseitigt werden. Serumproben sollten sofort nach der Blutentnahme zentrifugiert werden. Es muss berücksich-tigt werden, dass Post-mortem-Serum in seltenen Fällen zur Verstopfung der Pipettiersysteme durch Clotting füh-ren kann. Schlussfolgerung: Es gibt keine Anzeichen dafür, dass Post-mortem-Proben mit dem verwendeten Testsystem zu falsch-negativen oder falsch-positiven Ergebnissen führen. Die beschriebene Vorgehensweise könnte als Modell für die Validierung postmortaler Proben mit weiteren Testsystemen dienen.
Introduction
The spectrum of transplanted tissues ranges from musculoskeletal preparations (bone, cartilage, tendons, ligaments, fascia) over cornea to cardiovascular allografts (aortic valves, pulmonary valves, pericardium, veins, arteries). Each year about 30,000-35,000 tissue preparations are transplanted in Germany. Donor suitability criteria regarding blood donors and tissue donors have many points in common. The basic requirements for the viral safety of blood donations were defined in the Guidelines for the Preparation of Blood and Blood Components and for the Application of Blood Products (Hemotherapy) (Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämo-therapie)) [1] In accordance with the EU directive 2006/17, pre-mortem blood samples from the deceased donors should have been centrifuged immediately after blood collection, not be older than 7 days, and stored at 2 -8 C. If these pre-mortem samples are not available, post-mortem blood may be used, which Pre-dilution none 100 l from the original tube + 1,900 l serum* Pipetting, l 5 l from the original tube + 495 l post-mortem serum 5 l of 1:20 pre-dilution + 495 l post-mortem serum *Negative blood donor serum. 
Results

Tissue Donors
Consent for tissue removal and serological tests were obtained in advance under the provisions of the German Transplantation Law (Transplantationsgesetz; TPG). All pre-mortal samples obtained up to 7 days before death were unequivocally negative in all tests. The post-mortal blood samples were taken from 6 female and 14 male donors at the time of cornea removal. The median age of the donors was 68 years (49-77 years). The post-mortem blood samples were collected between 4 and 52 h post mortem. The blood samples for the additional anti-HIV-low tests were taken from 10 female and 10 male donors at the time of cornea re--HBV: HBsAg: PEI HBsAg ad 1,000 standard, 100 PEI U/ml, 600 l -HBV: anti-HBc IgG (WHO) NIBSC code: 95/522, 100 IU/ml, 500 l -HIV: anti-HIV-1: PEI anti-HIV-IV reference material, 500 l after reconstitution. The standards may be ordered at:
The first aliquot of the post-mortem sample was tested unspiked as a negative control, the second aliquot was spiked with a high dilution of antigen or antibody, with expected results near the cut-off value (low-spiked), and the third aliquot, except for anti-HBc, was spiked with a high concentration of the antigen or antibody (high-spiked). The spiking was performed using a calibrated Biomaster ® Eppendorf pipette. The exact details of supplies and dilution volumes are shown in tables 1-4. The freezedried standards (PEI anti-HCV IgG, anti-HIV-IV) were dissolved in a sodium chloride solution (isotonic sodium chloride solution 0.9%, Braun, Melsungen, Germany). The required pre-dilutions of the standards (anti-HIV-IV, HBsAg ad 1,000 standard) were obtained by using serologically negatively tested human serum of blood donors. The blood sample volume per test was 500 l. sive total volume due to double-pipetting). No differences dependent on post-mortem blood collection time, age, or sex could be demonstrated. This means that the extinction of the samples did not change noticeably with increasing post-mortem removal time (table 6) .
Test Kits
Anti-HBc Post-mortem Testing
All unspiked samples were true-negative. All low-spiked samples for anti-HBc showed true-positive results. Neither falsenegative, nor false-positive findings were recorded. No differences dependent on post-mortem blood collection time, age, or sex could be demonstrated, i.e., the extinction of the samples did not change noticeably with increasing post-mortem removal time (table 7) . After consultation with the PEI, the validation of high-spiked samples was not performed.
Anti-HIV Post-mortem Testing
All unspiked samples were true-negative. No differences dependent on post-mortem blood collection time, age, or sex could be demonstrated, that is the extinction of the samples did not change noticeably with increasing post-mortem removal time (table 8) .
moval. The median age of the donors was 61.5 years (39-74 years). The blood samples were collected between 4 and 47 h post mortem.
Anti-HCV Post-mortem Testing
All unspiked samples were confirmed negative. Both the lowand high-spiked samples showed correct positive results for anti-HCV. False-negative or false-positive results were not observed. Furthermore, no differences depending on postmortem blood collection time, age, or sex could be demonstrated. The extinction of the samples did not change noticeably with increasing post-mortem removal time (table 5) .
HBsAg Post-mortem Testing 20/20 unspiked samples were true-negative. All high-spiked samples, and 19/20 with the low-spiked samples tested for HBsAg showed correct positive results. In 1/20 samples (no. 17), the value for the low-spiked sample was in the range of the negative control and for the high-spiked sample remarkably lower than for the other 19 high-spiked samples. After examining sample no. 17, a pipetting error in the quantity of post-mortem serum could be determined as the cause (exces- (table 10) . In 2/20 samples a pipette blockage during the analysis occurred so that the findings could not be counted. Here again, no differences dependent on post-mortem blood collection time, age, or sex could be demonstrated, that is, the extinction of the samples did not change noticeably with increasing post-mortem removal time.
Discussion
Post-mortem modifications might give false-negative or falsepositive results in infectious disease testing due to hemolysis, autolysis, and bacterial growth. Most CE-marked test equipment for infectious serology testing is not validated for testing post-mortem blood. A recently published study shows that no false-negative results appear when taking blood up to 48 h post mortem under standardized conditions from HIV-, HCV-, and/or HBV-infected cadavers [9] . Up to now no study compares the results of infection testing in pre-mortem and postmortem samples of the same donors. Hence, this study was performed using low-spiked and high-spiked post-mortem All high-spiked samples for anti-HIV showed true-positive results. However, in the first measurement series of low-spiked samples we found 18/20 samples false-negative and only 2/20 samples true-positive (table 8) . Thus, we assumed that the chosen dilution of 1:5,000 was too low to generate reactive results. Therefore, we repeated the measurement with a dilution of 1:4,000 using 10 new low-spiked samples. All results were truepositive, but the results of the 1:4,000 dilution showed unexpected high values (table 9) . Because of this, we performed a second test series with 20 low-spiked samples using the dilution 1:5,000 (table 10). In order to additionally investigate both the influence of the time period before centrifugation and the storage conditions, the cadaveric blood samples no. 11-20 were immediately centrifuged after blood collection and frozen, while the samples no. 1-10 were handled as whole blood for up to 7 days, stored at 2-8 °C in the refrigerator, and centrifuged only directly prior to measurement.
Including the results of the comparison 1:4,000 versus 1:5,000 dilution ( MONO) ) on the BEP-III automatic system from Siemens is suitable for routine testing and leads to valid results. No false-negative or false-positive results were shown in the test series for HBsAg, anti-HCV, and anti-HBc. In the first test series of the HIV-low validation, false-negative findings occurred in almost all the tests. The cause of the false-negative reactions should be considered as a systematic pipetting error. In a second test series of the anti-HIV validation, the low-spiked samples were tested true-positive, and the values were suitable as a standard low control. The false-negative result in one case is probably caused by the pre-analytical conditions. Because this sample was stored uncentrifuged in the refrigerator and the serum was obtained just before spiking, inhibiting effects on the added spiking material may have occurred. This could also ex- 
